487
Views
26
CrossRef citations to date
0
Altmetric
Review Articles

HLA-B51 Carriers are Susceptible to Ocular Symptoms of Behçet Disease and the Association between the Two Becomes Stronger towards the East along the Silk Road: A Literature Survey

, MD, , PhD, , MD, , MD ORCID Icon, , MD, , MD, , MD, , MD, , PhD, , PhD, , MD, , MD & , MD show all
Pages 37-40 | Received 20 Jun 2015, Accepted 22 Dec 2015, Published online: 08 Mar 2016

REFERENCES

  • Ohno S, Ohguchi M, Hirose S, et al. Close association of HLA-Bw51 with Behçet’s disease. Arch Ophthalmol. 1982;100:1455–1458.
  • Ohno S, Aoki K, Sugiura S, et al. Letter: HL-A5 and Behçet’s disease. Lancet. 1973;2:1383–1384.
  • Choukri F, Chakib A, Himmich H, et al. HLA-B*51 and B*15 alleles confer predisposition to Behçet’s disease in Moroccan patients. Hum Immunol. 2001;62:180–185.
  • Houman MH, Neffati H, Braham A, et al. Behçet’s disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients. Clin Exp Rheumatol. 2007;25(4 Suppl 45):S58–S64.
  • Kilmartin DJ, Finch A, Acheson RW. Primary association of HLA-B51 with Behçet’s disease in Ireland. Br J Ophthalmol. 1997;81:649–653.
  • Yazici H, Chamberlain MA, Schreuder I, et al. HLA antigens in Behçet’s disease: a reappraisal by a comparative study of Turkish and British patients. Ann Rheum Dis. 1980;39:344–348.
  • Gemignani G, Berrettini S, Bruschini P, et al. Hearing and vestibular disturbances in Behçet’s syndrome. Ann Otol Rhinol Laryngol. 1991;100:459–463.
  • Boura P, Tselios K, Skendros P, et al. Adamantiades-Behcet disease (ABD) in northern Greece patients: experience from a single center. Hippokratia. 2007;11:210–215.
  • Koumantaki Y, Stavropoulos C, Spyropoulou M, et al. HLA-B*5101 in Greek patients with Behçet’s disease. Hum Immunol. 1998;59:250–255.
  • Verity DH, Wallace GR, Vaughan RW, et al. HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet’s disease. Tissue Antigens. 1999;54:264–272.
  • Chajek-Shaul T, Pisanty S, Knobler H, et al. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet’s syndrome. Am J Med. 1987;83:666–672.
  • Gul A, Uyar FA, Inanc M, et al. Lack of association of HLA-B*51 with a severe disease course in Behçet’s disease. Rheumatology. 2001;40:668–672.
  • Krause L, Kohler AK, Altenburg A, et al. Ocular involvement is associated with HLA-B51 in Adamantiades–Behçet’s disease. Eye (Lond). 2009;23:1182–1186.
  • Chung YM, Tsai ST, Liao F, et al. A genetic study of Behçet’s disease in Taiwan Chinese. Tissue Antigens. 1987;30:68–72.
  • Kim MS, Kim JH. Prognostic comparison of Behçet’s disease with or without HLA-Bw 51 antigen. Korean J Ophthalmol. 1989;3:85–89.
  • Chang HK, Kim JU, Cheon KS, et al. HLA-B51 and its allelic types in association with Behçet’s disease and recurrent aphthous stomatitis in Korea. Clin Exp Rheumatol. 2001;19(5 Suppl 24):S31–S35.
  • Mizuki N, Inoko H, Ando H, et al. Behçet’s disease associated with one of the HLA-B51 subantigens, HLA-B*5101. Am J Ophthalmol. 1993;116:406–409.
  • Mizuki N, Ota M, Katsuyama Y, et al. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet’s disease. Arthritis Rheum. 1999; 42:1961–1966.
  • Gonzalez-Galarza FF, Christmas S, Middleton D, et al. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res. 2011;39(Database issue):D913–D919.
  • Maldini C, Lavalley MP, Cheminant M, et al. Relationships of HLA-B51 or B5 genotype with Behçet’s disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatology. 2012;51:887–900.
  • de Menthon M, Lavalley MP, Maldini C, et al. HLA-B51/B5 and the risk of Behçet’s disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009;61:1287–1296.
  • Mizuki N, Meguro A, Ota M, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet’s disease susceptibility loci. Nat Genet. 2010;42:703–706.
  • Lee YJ, Horie Y, Wallace GR, et al. Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behçet’s disease. Ann Rheum Dis. 2013;72:1510–1516.
  • Meguro A, Inoko H, Ota M, et al. Genetics of Behcet disease inside and outside the MHC. Ann Rheum Dis. 2010;69:747–754.
  • Mishima S, Masuda K, Izawa Y, et al. The eighth Frederick H. Verhoeff Lecture presented by Saiichi Mishima, MD. Behçet’s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc. 1979;77:225–279.
  • Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol. 1996;114:593–599.
  • Kaneko F, Oyama N, Yanagihori H, et al. The role of streptococcal hypersensitivity in the pathogenesis of Behçet’s Disease. European J Dermatol. 2008;18:489–498.
  • Kaneko F, Togashi A, Saito S, et al. Behçet’s disease (Adamantiades-Behçet’s disease). Clin Dev Immunol. 2011; 2011: 681956.
  • Pehlivan M, Kurtuncu M, Tuzun E, et al. The comparison of socio-economic conditions and personal hygiene habits of neuro-Behçet’s disease and multiple sclerosis patients. Int J Hyg Environ Health. 2011;214:335–337.
  • Douwes J, Thorne P, Pearce N, et al. Bioaerosol health effects and exposure assessment: progress and prospects. Ann Occup Hyg. 2003;47:187–200.
  • Celenk C, Aydin F, Unsal M. Pulmonary alterations in Behçet’s disease. Eur J Radiol. 2009;70:317–319.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.